The General Pharmaceutical Council (GPhC) have published the new guidance for prescribing weight loss injections such as ...

While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

The governing board of the State Health Plan is expected to give state treasurer Brad Briner the go-ahead Friday to overhaul ...

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online ...

Welcome to the full-year 2024 Novo Nordisk earnings conference call. [Operator instructions] Please be advised that today's ...

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...

A large cohort study examining more than 125,000 adults in the U.S. found that the majority of patients discontinue GLP-1 RA therapy within the first year, with those without Type 2 diabetes showing ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The company behind popular weight-loss drugs failed to disclose millions of pounds it paid to healthcare groups and patient ...